Abstract
The primary purpose of this research is to examine the impact of taking risperidone by psychotic individuals on serum levels of prolactin hormone as well as a few biochemical indicators (total protein and liver enzymes AST and ALT). The experiment required collecting fifty blood samples and dividing them into two groups: the first group consisted of normal, healthy persons who served as a control. In contrast, the second group consisted of psychotic patients treated with risperidone at a dosage of two milligrams per day. The findings of this study showed that There were significant increases in total protein content at levels (P≤ 0.05) of the group 2 compared to control, and there were significant gains in liver enzymes (AST and ALT) concentration range at levels (P ≤0.05) of the second group in comparison to the control group, and there were substantial improvements increases in prolactin hormone concentrations at levels (P≤ 0.05) of the second group in compared to control.
Reference17 articles.
1. Folquitto, J. C., Barros, S. B., Pinto Junior, J. A., & Bottino, C. M. C. (2010). Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study. Dementia & Neuropsychologia, 4(1), 69–74. https://doi.org/10.1590/s1980-57642010dn40100012.
2. Raja, M. (2009). Pharmacotherapy update: Risperidone in the treatment of schizophrenia. Clinical Medicine. Therapeutics, 1. https://doi.org/10.4137/cmt.s1123.
3. Bernard, V., Young, J., & Binart, N. (2019). Prolactin — a pleiotropic factor in health and disease. Nature Reviews Endocrinology, 15(6), 356–365. https://doi.org/10.1038/s41574-019-0194-6.
4. Saleem, M.; Martin, H. and Coates, P. (2018). Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues. Clin Biochem Rev 39 (1) , pp:3-16.
5. Aboraya, A. ; Fullen, J. E.; Ponieman, B. L. ; Makela , E. H. and Latocha , M. (2004). Hyperprolactinemia Associated with Risperidone: A Case Report and Review of Literature. Psychiatry [November] , pp:29-31.